A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia

Monte Carlo Simulations Based on Phase 1 Studies Predict Target Attainment of Ceftobiprole in Nosocomial Pneumonia Patients: a Validation Study

(2013) Anouk E. Muller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model

(2013) Y. Barnea et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Ceftobiprole EfficacyIn Vitroagainst Panton-Valentine Leukocidin Production andIn Vivoagainst Community-Associated Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rabbits

(2012) Azzam Saleh-Mghir et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone

(2012) Todd A. Davies et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation

(2012) Susan C. Nicholson et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Structural Insights into the Anti-methicillin-resistantStaphylococcus aureus(MRSA) Activity of Ceftobiprole

(2012) Andrew L. Lovering et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Evaluation of Ceftobiprole Activity against a Variety of Gram-Negative Pathogens, Including Escherichia coli, Haemophilus influenzae (β-Lactamase Positive and β-Lactamase Negative), and Klebsiella pneumoniae, in a Rabbit Meningitis Model

(2011) A. Stucki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of beta-lactam antibiotics to community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)

(2011) C. Germel et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator‐Associated Pneumonia and Hospital‐Acquired Pneumonia

(2010) John G. Muscedere et al.   CLINICAL INFECTIOUS DISEASES

Use of Severity Scoring and Stratification Factors in Clinical Trials of Hospital‐Acquired and Ventilator‐Associated Pneumonia

(2010) Lena M. Napolitano   CLINICAL INFECTIOUS DISEASES

Treatment Guidelines and Outcomes of Hospital‐Acquired and Ventilator‐Associated Pneumonia

(2010) Antoni Torres et al.   CLINICAL INFECTIOUS DISEASES

Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia

(2010) Ronald N. Jones   CLINICAL INFECTIOUS DISEASES

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

(2010) E. Rubinstein et al.   CLINICAL INFECTIOUS DISEASES

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia

(2010) Antonio T. Freire et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models

(2010) Molière Nguile-Makao et al.   INTENSIVE CARE MEDICINE

Comparative in vitro activity of ceftobiprole against Gram-positive cocci

(2010) Carmen Betriu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ceftobiprole

(2009) George G Zhanel et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

In Vivo Activity of Ceftobiprole in Murine Skin Infections Due to Staphylococcus aureus and Pseudomonas aeruginosa

(2009) J. Fernandez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftobiprole Is Superior to Vancomycin, Daptomycin, and Linezolid for Treatment of Experimental Endocarditis in Rabbits Caused by Methicillin-Resistant Staphylococcus aureus

(2009) P. Tattevin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure Infections

(2008) K. M. Amsler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacies of Ceftobiprole Medocaril and Comparators in a Rabbit Model of Osteomyelitis Due to Methicillin-Resistant Staphylococcus aureus

(2008) L.-Y. Yin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study

(2008) Álvaro Réa-Neto et al.   CURRENT MEDICAL RESEARCH AND OPINION